In a study published in Advanced Functional Materials, a research team from the Shanghai Institute of Materia Medica (SIMM) ...

All medicines have risks and benefits. Your doctor has weighed the risks of you using oxaliplatin against the benefits they expect it will have for you. If you have any concerns about taking this ...

Researchers investigated the efficacy of total neoadjuvant treatment followed by nonoperative management in patients with locally advanced rectal cancer.

The new biotech has inherited two T cell engager antibodies as part of a three-way merger with Vignette and TRC 2004.

Medscape Oncology, March 08, 2024 Oxaliplatin in Older Adults With Resected Colorectal Cancer? Dr David Kerr discusses the use of adjuvant chemotherapy with oxaliplatin to high-risk patients with ...

This white-hot metal not only makes beautiful jewelry, it's coveted for industrial, medical and military purposes too.

CRC is an abnormal growth of cells that begins in a part of the large intestine called the colon. When the cancer is ...

Lowered costs and incremental effectiveness could improve when using biomarker-guided selection for treatment of patients ...

The UK’s MHRA has approved Takeda’s Fruzaqla (fruquintinib) for metastatic colorectal cancer (CRC) in adults who have not ...

The combination of ramucirumab with trifluridine/tipiracil failed to show improvements in overall survival vs TAS-102 alone ...

Treatment with Cyramza plus Lonsurf did not improve overall survival compared with Lonsurf alone in heavily pretreated ...

Johnson & Johnson (NYSE:JNJ) today announced new data from the Phase 1b/2 OrigAMI-1 study, which showed RYBREVANT® (amivantamab-vmjw) combined with chemotherapy (mFOLFOX6 [FOLFOX] or FOLFIRI) ...